MARIANNE ADKINS: Open Payments
NPI 1841908365 · ERLANGER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 36 payments from 11 companies in 2025. Trend: 2023 $1,829 · 2024 $1,265 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $210 |
| Teva Pharmaceuticals USA, Inc. | 9 | $149 |
| ABBVIE INC. | 5 | $136 |
| Biogen, Inc. | 1 | $106 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Luye Pharma (USA) Ltd. | 4 | $76 |
| Noven Therapeutics, LLC | 2 | $42 |
| Indivior Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, ZURZUVAE, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, Secuado, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
